Cytokine gene polymorphisms predict acute graft rejection following renal transplantation

Kidney International

Volumn 56, Issue 1, 1999, Pages 281-288

  Sankaran, David ^b   Asderakis, Argiris ^b   Ashraf, Shazad ^b   Roberts, Ian S D ^b   Short, Colin D ^b   Dyer, Philip A ^b   Sinnott, Paul J ^b   Hutchinson, Ian V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

Acute rejection; Chronic renal dysfunction; Cytokines; Graft survival; Interleukin 10; Kidney transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYTOKINE; DNA; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; OKT 3; PREDNISOLONE; STEROID; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DRUG RESISTANCE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; RECIPIENT;

EID: 0033063027     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00536.x     Document Type: Article

References (11)

1. CECKA JM, TERASAKI PI: The UNOS Scientific Renal Transplant Survey, in Clinical Transplants, edited by Terasaki PI, Cecka JM, Los Angeles, UCLA Tissue Typing Laboratory, 1994
2. LINDHOLM A, OHLMAN S, ALBRECHTSEN D, TUFVESON G, PERSSON H, PERSSON NH: The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 56:307-315, 1993
3. VANRENTERGHEM YF: Acute rejection and renal allograft outcome. Nephrol Dial Transplant 10(Suppl 1):29-31, 1995
4. SAYEGH MH, WATSCHINGER B, CARPENTER CB: Mechanisms of T cell recognition of alloantigen: The role of peptides. Transplantation 57:1295-1302, 1994
5. MOSMANN TR, SAD S: The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
6. MCLAUGHLIN PJ, AIKAWA A, DAVIES HM, WARD RG, BAKRAN A, SELLS RA, JOHNSON PM: Evaluation of sequential plasma and urinary tumour necrosis factor alpha levels in renal allograft recipients. Transplantation 51:1225-1229, 1991
7. HEIDENREICH S, LANG D, TEPEL M, RAHN KH: Monocyte activation for enhanced tumour necrosis factor-α and interleukin 6 production during chronic renal allograft rejection. Transplant Immunol 2:35-40, 1994
8. LUSCINSKAS FW, CYBULSKY MI, KIELY JM, PECKINS CS, DAVIS VM, GIMBRONE MA JR: Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 146:1617-1625, 1991
9. RENKONEN R, TURUNEN JP, RAPOLA J, HÄYRY P: Characterisation of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection. Am J Pathol 137:643-651, 1990
10. TRIPP CS, WOLF SF, UNANUE ER: Interleukin-12 and tumour necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listerosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725-3729, 1993
11. CHANG CH, FURUE M, TAMAKI K: Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol 24:2889-2895, 1994